A Look Back at Risk Evaluation and Mitigation Strategies at the Food and Drug Administration in 2020: Year in Review

In the latest issue of the Food and Drug Law Institute (FDLI) Update Magazine, David Shotlander provides an overview of major FDA Risk Evaluation and Mitigation Strategies (REMS) news from the past year, including

To read the full article A Look Back at Risk Evaluation and Mitigation Strategies at the Food and Drug Administration in 2020: Year in Review with permission of FDLI, please visit here.